Telor Ophthalmic Pharmaceuticals Inc. announced Thursdaythat the underwriters of its initial public offering havepurchased 375,000 shares of common stock to coveroverallotments for the offering. Alex. Brown & Sons Inc. wasthe managing underwriter for the IPO, which completed onMay 12, grossing $20 million on sales of 2.5 million shares ofcommon stock at $8 a share for the Woburn, Mass., company.
The stock (NASDAQ:TELR) gained 25 cents on Thursday to closeat $8.13 a share.
(c) 1997 American Health Consultants. All rights reserved.